Loading...
Docoh

Acelrx Pharmaceuticals (ACRX)

557 filings

Page 5 of 28
Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
424B5
ACRX Acelrx Pharmaceuticals Inc
19 Jan 21
Prospectus supplement for primary offering
4:31pm
8-K
ACRX Acelrx Pharmaceuticals Inc
14 Jan 21
AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements
8:53am
424B5
ACRX Acelrx Pharmaceuticals Inc
10 Dec 20
Prospectus supplement for primary offering
4:17pm
8-K
ACRX Acelrx Pharmaceuticals Inc
10 Dec 20
Securities Purchase Agreement
4:16pm
10-Q
2020 Q3
ACRX Acelrx Pharmaceuticals Inc
5 Nov 20
Quarterly report
4:32pm
8-K
ACRX Acelrx Pharmaceuticals Inc
5 Nov 20
AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results
4:16pm
SC 13G
ACRX Acelrx Pharmaceuticals Inc
27 Oct 20
ACELRX PHARMACEUTICALS / BML Investment Partners ownership change
4:04pm
SC 13G
BML Investment Partners, L.P.
27 Oct 20
ACELRX PHARMACEUTICALS / BML Investment Partners ownership change
3:50pm
8-K
ACRX Acelrx Pharmaceuticals Inc
6 Oct 20
Entry into a Material Definitive Agreement
4:07pm
10-Q
2020 Q2
ACRX Acelrx Pharmaceuticals Inc
10 Aug 20
Quarterly report
4:20pm
8-K
ACRX Acelrx Pharmaceuticals Inc
10 Aug 20
AcelRx Pharmaceuticals Reports Second Quarter 2020 Financial Results
4:01pm
424B5
ACRX Acelrx Pharmaceuticals Inc
23 Jul 20
Prospectus supplement for primary offering
4:39pm
8-K
ACRX Acelrx Pharmaceuticals Inc
23 Jul 20
AcelRx expands DSUVIA commercial opportunity with an established, leading partner to advance surgical care
8:50am
EFFECT
ACRX Acelrx Pharmaceuticals Inc
9 Jul 20
Notice of effectiveness
12:15am
CORRESP
ACRX Acelrx Pharmaceuticals Inc
6 Jul 20
Correspondence with SEC
8:00pm
CORRESP
ACRX Acelrx Pharmaceuticals Inc
5 Jul 20
Correspondence with SEC
8:00pm
CORRESP
ACRX Acelrx Pharmaceuticals Inc
5 Jul 20
Correspondence with SEC
8:00pm
EFFECT
ACRX Acelrx Pharmaceuticals Inc
18 Jun 20
Notice of effectiveness
12:15am
UPLOAD
ACRX Acelrx Pharmaceuticals Inc
16 Jun 20
Letter from SEC
8:00pm
4
Afable Richard
16 Jun 20
ACELRX PHARMACEUTICALS / Richard Afable ownership change
7:17pm